List of Tables
Table 1. Global DTaP and Tdap Vaccines Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global DTaP and Tdap Vaccines Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global DTaP and Tdap Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers DTaP and Tdap Vaccines Covered in This Study
Table 5. Global DTaP and Tdap Vaccines Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global DTaP and Tdap Vaccines Sales Share by Manufacturers (2016-2021)
Table 7. Global DTaP and Tdap Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global DTaP and Tdap Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market DTaP and Tdap Vaccines Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers DTaP and Tdap Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers DTaP and Tdap Vaccines Product Type
Table 12. Global DTaP and Tdap Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global DTaP and Tdap Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DTaP and Tdap Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global DTaP and Tdap Vaccines Sales by Region (2016-2021) & (K Units)
Table 16. Global DTaP and Tdap Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global DTaP and Tdap Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America DTaP and Tdap Vaccines Sales by Country (2016-2021) & (K Units)
Table 19. North America DTaP and Tdap Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America DTaP and Tdap Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America DTaP and Tdap Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe DTaP and Tdap Vaccines Sales by Country (2016-2021) & (K Units)
Table 23. Europe DTaP and Tdap Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe DTaP and Tdap Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe DTaP and Tdap Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific DTaP and Tdap Vaccines Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific DTaP and Tdap Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America DTaP and Tdap Vaccines Sales by Country (2016-2021) & (K Units)
Table 31. Latin America DTaP and Tdap Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America DTaP and Tdap Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America DTaP and Tdap Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa DTaP and Tdap Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global DTaP and Tdap Vaccines Sales (K Units) by Type (2016-2021)
Table 39. Global DTaP and Tdap Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global DTaP and Tdap Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global DTaP and Tdap Vaccines Revenue Share by Type (2016-2021)
Table 42. Global DTaP and Tdap Vaccines Price (USD/Unit) by Type (2016-2021)
Table 43. Global DTaP and Tdap Vaccines Sales (K Units) by Application (2016-2021)
Table 44. Global DTaP and Tdap Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global DTaP and Tdap Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global DTaP and Tdap Vaccines Revenue Share by Application (2016-2021)
Table 47. Global DTaP and Tdap Vaccines Price (USD/Unit) by Application (2016-2021)
Table 48. Sanofi Pasteur Corporation Information
Table 49. Sanofi Pasteur Description and Business Overview
Table 50. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi Pasteur DTaP and Tdap Vaccines Product
Table 52. Sanofi Pasteur Recent Developments/Updates
Table 53. GlaxoSmithKline Corporation Information
Table 54. GlaxoSmithKline Description and Business Overview
Table 55. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. GlaxoSmithKline DTaP and Tdap Vaccines Product
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. Protein Sciences Corporation Corporation Information
Table 59. Protein Sciences Corporation Description and Business Overview
Table 60. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Protein Sciences Corporation DTaP and Tdap Vaccines Product
Table 62. Protein Sciences Corporation Recent Developments/Updates
Table 63. Novartis AG Corporation Information
Table 64. Novartis AG Description and Business Overview
Table 65. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Novartis AG DTaP and Tdap Vaccines Product
Table 67. Novartis AG Recent Developments/Updates
Table 68. Seqirus Corporation Information
Table 69. Seqirus Description and Business Overview
Table 70. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Seqirus DTaP and Tdap Vaccines Product
Table 72. Seqirus Recent Developments/Updates
Table 73. Merck Sharp & Dohme Corp Corporation Information
Table 74. Merck Sharp & Dohme Corp Description and Business Overview
Table 75. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product
Table 77. Merck Sharp & Dohme Corp Recent Developments/Updates
Table 78. Astellas Pharma US, Inc Corporation Information
Table 79. Astellas Pharma US, Inc Description and Business Overview
Table 80. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Astellas Pharma US, Inc DTaP and Tdap Vaccines Product
Table 82. Astellas Pharma US, Inc Recent Developments/Updates
Table 83. Pfizer Inc Corporation Information
Table 84. Pfizer Inc Description and Business Overview
Table 85. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Pfizer Inc DTaP and Tdap Vaccines Product
Table 87. Pfizer Inc Recent Developments/Updates
Table 88. Johnson & Johnson Corporation Information
Table 89. Johnson & Johnson Description and Business Overview
Table 90. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Johnson & Johnson DTaP and Tdap Vaccines Product
Table 92. Johnson & Johnson Recent Developments/Updates
Table 93. Lanzhou Institute of Biological Products Co., Ltd Corporation Information
Table 94. Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
Table 95. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product
Table 97. Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 98. AstraZeneca Corporation Information
Table 99. AstraZeneca Description and Business Overview
Table 100. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. AstraZeneca DTaP and Tdap Vaccines Product
Table 102. AstraZeneca Recent Developments/Updates
Table 103. Emergent BioSolutions Inc Corporation Information
Table 104. Emergent BioSolutions Inc Description and Business Overview
Table 105. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Emergent BioSolutions Inc DTaP and Tdap Vaccines Product
Table 107. Emergent BioSolutions Inc Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. DTaP and Tdap Vaccines Distributors List
Table 111. DTaP and Tdap Vaccines Customers List
Table 112. DTaP and Tdap Vaccines Market Trends
Table 113. DTaP and Tdap Vaccines Growth Drivers
Table 114. DTaP and Tdap Vaccines Market Restraints
Table 115. Global DTaP and Tdap Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 116. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 117. Global DTaP and Tdap Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global DTaP and Tdap Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 120. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 121. Global DTaP and Tdap Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global DTaP and Tdap Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 124. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 125. Global DTaP and Tdap Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of DTaP and Tdap Vaccines
Figure 2. Global DTaP and Tdap Vaccines Market Share by Type in 2020 & 2027
Figure 3. DTaP Product Picture
Figure 4. Td Product Picture
Figure 5. Tdap Product Picture
Figure 6. Global DTaP and Tdap Vaccines Market Share by Application in 2020 & 2027
Figure 7. Adult
Figure 8. Pediatric
Figure 9. Global DTaP and Tdap Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global DTaP and Tdap Vaccines Market Size 2016-2027 (US$ Million)
Figure 11. Global DTaP and Tdap Vaccines Sales 2016-2027 (K Units)
Figure 12. Global DTaP and Tdap Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. DTaP and Tdap Vaccines Sales Share by Manufacturers in 2020
Figure 14. Global DTaP and Tdap Vaccines Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest DTaP and Tdap Vaccines Players: Market Share by Revenue in 2020
Figure 16. DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global DTaP and Tdap Vaccines Sales Market Share by Region (2016-2021)
Figure 18. Global DTaP and Tdap Vaccines Sales Market Share by Region in 2020
Figure 19. Global DTaP and Tdap Vaccines Revenue Market Share by Region (2016-2021)
Figure 20. Global DTaP and Tdap Vaccines Revenue Market Share by Region in 2020
Figure 21. U.S. DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E DTaP and Tdap Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of DTaP and Tdap Vaccines by Type (2016-2021)
Figure 46. Sales Market Share of DTaP and Tdap Vaccines by Application (2016-2021)
Figure 47. Sales Market Share of DTaP and Tdap Vaccines by Application in 2020
Figure 48. Revenue Share of DTaP and Tdap Vaccines by Application (2016-2021)
Figure 49. Revenue Share of DTaP and Tdap Vaccines by Application in 2020
Figure 50. Manufacturing Cost Structure of DTaP and Tdap Vaccines
Figure 51. Manufacturing Process Analysis of DTaP and Tdap Vaccines
Figure 52. DTaP and Tdap Vaccines Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

LIST OF FIGURE